Antibody–drug conjugates in gastric cancer: from targeted cytotoxicity to immune modulation
Gastric cancer (GC) remains a major cause of cancer-related mortality, and therapeutic resistance and tumor heterogeneity continue to limit durable responses in advanced disease. Antibody–drug conjugates (ADCs), which combine the target specificity of monoclonal antibodies with highly potent cytotoxic payloads, have em...